Establishing Proposition 65 Safe Harbor Levels for Estragole and Methyleugenol in Cosmetics: A Mechanistic Read-Across from Safrole
Authors:
- Gabriela de Oliveira Prado CorrêaGabriela de Oliveira Prado Corrêa
- Tugstênio SouzaTSTugstênio Souza
- Eduarda Naomi Nakano CondeECEduarda Naomi Nakano Conde
- Andréia Ávila Soares OliveiraAOAndréia Ávila Soares Oliveira
- Natália Albuquerque VitaNVNatália Albuquerque Vita
- Carolina Motter CatarinoCCCarolina Motter Catarino
- Andrezza di Pietro Micali CanavezACAndrezza di Pietro Micali Canavez
Open Access
Abstract
California’s Proposition 65 requires warning labels for chemicals associated with carcinogenicity or reproductive toxicity, affecting global cosmetic and fragrance formulations. While safrole has an established safe harbor level (No Significant Risk Level, NSRL) of 3 µg/day, its structural analogues, estragole and methyleugenol, lack specific safe harbor thresholds. To address this data gap using non-animal methodologies, this study evaluated a Next-Generation Risk Assessment (NGRA) workflow combining read-across and in silico modeling. Structural, physicochemical, and skin-permeation profiling supported category homogeneity (Tanimoto Tc ≥ 0.82 and comparable log Kp values) in accordance with OECD and ECHA guidelines. Multi-platform QSAR consensus (ToxTree, Danish QSAR, and VEGA QSAR) indicated that while parent phenylpropenes lack direct bacterial mutagenicity, they share a hepatic bioactivation pathway leading to mammalian clastogenicity and carcinogenicity predictions. Molecular docking with human Cytochrome P450 1A2 (CYP1A2; PDB: 2H14) identified safrole as the category’s conservative toxicological benchmark, exhibiting the highest binding affinity (−8.026 kcal/mol) and closest proximity to the catalytic HEME iron. Consequently, applying safrole’s 3 µg/day NSRL to estragole and methyleugenol provides a quantitative threshold to evaluate consumer exposure in cosmetic products, ensuring public health protection and regulatory compliance.Keywords
This publication has 31 references indexed in Scilit:
- Mode of action-based risk assessment of genotoxic carcinogensArchives of Toxicology, 2020
- Computational prediction of cytochrome P450 inhibition and inductionDrug Metabolism and Pharmacokinetics, 2020
- The implementation of RAAF in the OECD QSAR ToolboxRegulatory Toxicology and Pharmacology, 2019
- Protein-Ligand Docking in Drug Design: Performance Assessment and Binding-Pose Selection2018
- A strategy for structuring and reporting a read-across prediction of toxicityRegulatory Toxicology and Pharmacology, 2015
- Physiologically based biokinetic model of bioactivation and detoxification of the alkenylbenzene methyleugenol in ratToxicology in Vitro, 2011
- A physiologically based biodynamic (PBBD) model for estragole DNA binding in rat liver based on in vitro kinetic data and estragole DNA adduct formation in primary hepatocytesToxicology and Applied Pharmacology, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Similarity-based virtual screening using 2D fingerprintsDrug Discovery Today, 2006
- Computer-based bioassay for evaluation of sensory irritation of airborne chemicals and its limit of detectionArchives of Toxicology, 1998